{"id":180410,"date":"2024-01-13T12:22:32","date_gmt":"2024-01-13T18:22:32","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/01\/theres-a-paradigm-shift-in-immunology-and-big-pharma-is-paying-richly-for-it"},"modified":"2024-01-13T12:22:32","modified_gmt":"2024-01-13T18:22:32","slug":"theres-a-paradigm-shift-in-immunology-and-big-pharma-is-paying-richly-for-it","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/01\/theres-a-paradigm-shift-in-immunology-and-big-pharma-is-paying-richly-for-it","title":{"rendered":"There\u2019s A Paradigm Shift In Immunology; And Big Pharma Is Paying Richly For It"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/theres-a-paradigm-shift-in-immunology-and-big-pharma-is-paying-richly-for-it.jpg\"><\/a><\/p>\n<p>This is good news potentially. TL1A have the potential of helping with inflammatory bowel disease, and arthritis and inflammatory diseases but it won\u2019t come out, until half a decade from now.<\/p>\n<hr>\n<p>Biotech stock investors are hoping for a repeat performance from the suite of TL1A drugs.<\/p>\n<p><b>Proving The Drug\u2019s Merit<\/b><\/p>\n<p>First, the companies are looking to prove the drugs\u2019 merit in ulcerative colitis and Crohn\u2019s disease. So far, that venture has paid off handsomely for the biotech stocks involved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is good news potentially. TL1A have the potential of helping with inflammatory bowel disease, and arthritis and inflammatory diseases but it won\u2019t come out, until half a decade from now. Biotech stock investors are hoping for a repeat performance from the suite of TL1A drugs. Proving The Drug\u2019s Merit First, the companies are looking [\u2026]<\/p>\n","protected":false},"author":528,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-180410","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/180410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/528"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=180410"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/180410\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=180410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=180410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=180410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}